Resmetirom (MGL-3196) in Patients With Heterozygous Familial Hypercholesterolemia

J Am Coll Cardiol. 2022 Mar 29;79(12):1220-1222. doi: 10.1016/j.jacc.2022.01.023.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Heterozygote
  • Humans
  • Hyperlipoproteinemia Type II* / diagnosis
  • Hyperlipoproteinemia Type II* / genetics
  • Pyridazines*
  • Uracil / analogs & derivatives

Substances

  • Pyridazines
  • Uracil
  • resmetirom

Associated data

  • ClinicalTrials.gov/NCT03038022